Press release
Thalassemia Market Update 2024: to Reach USD 4.2 billion by 2031, Claims AMR Report
Thalassemia Market
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ ๐๐ก๐๐ฅ๐๐ฌ๐ฌ๐๐ฆ๐ข๐ ๐๐๐ซ๐ค๐๐ญ?
Growth & innovations in the pharmaceutical industry for the manufacturing of thalassemia drugs owing to massive pool of health conscious consumers serve as potential opportunities for the expansion of the global thalassemia market. Based on region, North America held the largest share in 2021, contributing to nearly half of the global thalassemia market share.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/15812
Covid-19 Scenario:
โข The outbreak of COVID-19 had disrupted workflows in the health care sector around the world. The thalassemia market experienced a decline in 2021, due to global economic recession led by COVID-19.
โข In addition, the COVID-19 outbreak disrupted the supply chain of thalassemia drugs across various end-user industries like hospitals and pharmacies.
โข However, the market is anticipated to witness recovery in 2021, and show stable growth in the coming future. This is attributed to the increase in adoption of various screening techniques during pregnancy for genetic abnormalities and proper counselling regarding thalassemia.
๐๐จ๐ฉ ๐๐ก๐๐ฅ๐๐ฌ๐ฌ๐๐ฆ๐ข๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข FRESENIUS SE & Co
โข KGaA (Fresenius Kabi)
โข Apotex Inc
โข Novartis AG
โข Pfizer Inc.
โข Sun Pharmaceutical Industries Limited
โข Alvogen Inc
โข Bluebirdbio
โข Bristol Myers Squibb Co.
โข Chiesi Farmaceutici S.p.A
โข Cipla Ltd.
The report provides a detailed analysis of these key players of the global thalassemia market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
๐๐ก๐๐ฅ๐๐ฌ๐ฌ๐๐ฆ๐ข๐ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
The research provides detailed segmentation of the global thalassemia market based on treatment, type, distribution channel, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
Based on treatment, the iron chelation therapy segment held the highest share in 2021, accounting for more than half of the global thalassemia market, and is expected to continue its leadership status during the forecast period. However, the others segment is expected to register the highest CAGR of 5.5% from 2022 to 2031.
Based on type, the alpha thalassemia segment accounted for the highest share in 2021, contributing to more than three-fourths of the global thalassemia market, and is expected to maintain its lead in terms of revenue during the forecast period. This segment is expected to manifest the highest CAGR of 5.4% from 2022 to 2031.
Based on distribution channel, the drug stores and retail pharmacies segment accounted for the highest share in 2021, holding more than half of the global thalassemia market, and is expected to continue its leadership status during the forecast period. However, the online providers segment is estimated to grow at the highest CAGR of 6.7% during the forecast period.
Based on region, North America held the largest share in 2021, contributing to nearly half of the global thalassemia market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 6.8% during the forecast period.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/15812
Key Benefits For Stakeholders
โข This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic implants market analysis from 2022 to 2032 to identify the prevailing orthopedic implants market opportunity.
โข The market research is offered along with information related to key drivers, restraints, and opportunities.
โข Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
โข In-depth analysis of the orthopedic implants market segmentation assists to determine the prevailing market opportunities.
โข Major countries in each region are mapped according to their revenue contribution to the global market.
โข Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
โข The report includes the analysis of the regional as well as global orthopedic implants market trends, key players, market segments, application areas, and market growth strategies.
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
Region Analysis
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thalassemia Market Update 2024: to Reach USD 4.2 billion by 2031, Claims AMR Report here
News-ID: 3480344 • Views: โฆ
More Releases from Allied Market Research (AMR)
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521
Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849
Market Drivers and Challenges:
- The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654
What is Sunflower Lecithin?
Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156
Market Drivers, Restraints, and Opportunities
Drivers:
- Technological advancements and innovations inโฆ
More Releases for Thalassemia
Beta Thalassemia Market Trends, Treatment Landscape, and Growth Opportunities
Introduction
Beta thalassemia is a genetic blood disorder caused by mutations in the beta-globin gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This results in anemia, fatigue, and a range of complications that can be life-threatening if untreated. The severity of beta thalassemia varies from thalassemia minor, which typically requires no treatment, to thalassemia major (Cooley's anemia), which can lead to severe symptoms and require frequentโฆ
Global Thalassemia Market Size โ Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages andโฆ
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such thatโฆ
Thalassemia Treatment Market is driven by increase in number of altered thalasse โฆ
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapyโฆ
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptomsโฆ
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a personโs body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesnโt have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemiaโฆ
